HLA-DO β Antibodies

Santa Cruz Biotechnology provides a broad selection of HLA-DO β monoclonal antibodies for advanced research in immunology and cell biology. The monoclonal antibodies demonstrate high effectiveness in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HLA-DO β is a crucial component of the major histocompatibility complex (MHC) class II molecules, playing a significant role in the regulation of immune responses. It is involved in the presentation of antigens to CD4+ T cells, influencing the activation and differentiation of immune cells. Understanding the function of HLA-DO β is essential for elucidating mechanisms of immune tolerance and autoimmunity. HLA-DO β research has revealed important insights into antigen presentation pathways and their regulation in immune cells. Investigating HLA-DO β expression patterns helps researchers understand cellular immune responses in various physiological and pathological conditions. The role of HLA-DO β in autoimmune disorders continues to be an active area of investigation in immunology research. Santa Cruz Biotechnology monoclonal antibodies for HLA-DO β support researchers worldwide in advancing our understanding of immune system regulation and potential therapeutic applications.